Studying protein degradation pathways in vivo using a cranial window-based approach

Methods

Volumn 53, Issue 3, 2011, Pages 194-200

  Unni, Vivek K ^a   Ebrahimi Fakhari, Darius ^a,b   Vanderburg, Charles R ^c   McLean, Pamela J ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c The Harvard Center for Neurodegeneration & Repair   (United States)

Author keywords

Cortex; Cranial window; In vivo; Mouse; Protein degradation; Ubiquitin proteasome system

Indexed keywords

LACTACYSTIN BETA LACTONE; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN SLICE; CRANIAL WINDOW SURGERY; DEGENERATIVE DISEASE; IMMUNOBLOTTING; LASER CAPTURE MICRODISSECTION; MICROSCOPY; MOUSE; MULTIPHOTON IMAGING; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROSURGERY; NONHUMAN; PARKINSON DISEASE; PERIOSTEUM; PHOTON; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCALP; SKULL;

ACETYLCYSTEINE; ANIMALS; BLOTTING, WESTERN; CRANIOTOMY; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICROSCOPY, CONFOCAL; MICROTOMY; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

ANIMALIA; MAMMALIA;

EID: 79952185361     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2010.12.032     Document Type: Article

References (22)

1. Goldberg A.L. Nature 2003, 426:895-899.
2. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Nature 2008, 451:1069-1075.
3. Gregori L., Fuchs C., Figueiredo-Pereira M.E., Van Nostrand W.E., Goldgaber D. J. Biol. Chem. 1995, 270:19702-19708.
4. McNaught K.S., Jenner P. Neurosci. Lett. 2001, 297:191-194.
5. Stefanis L., Larsen K.E., Rideout H.J., Sulzer D., Greene L.A. J. Neurosci. 2001, 21:9549-9560.
6. Urushitani M., Kurisu J., Tsukita K., Takahashi R. J. Neurochem. 2002, 83:1030-1042.
7. Bennett M.C., Bishop J.F., Leng Y., Chock P.B., Chase T.N., Mouradian M.M. J. Biol. Chem. 1999, 274:33855-33858.
8. Ancolio K., Alves da Costa C., Ueda K., Checler F. Neurosci. Lett. 2000, 285:79-82.
9. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., Rubinsztein D.C. J. Biol. Chem. 2003, 278:25009-25013.
10. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Science 2004, 305:1292-1295.
11. Trachtenberg J.T., Chen B.E., Knott G.W., Feng G., Sanes J.R., Welker E., Svoboda K. Nature 2002, 420:788-794.
12. Minlebaev M., Ben-Ari Y., Khazipov R. J. Neurophysiol. 2007, 97:692-700.
13. Amruthesh S.C., Falck J.R., Ellis E.F. J. Neurochem. 1992, 58:503-510.
14. Levasseur J.E., Wei E.P., Raper A.J., Kontos A.A., Patterson J.L. Stroke 1975, 6:308-317.
15. Grinvald A., Frostig R.D., Siegel R.M., Bartfeld E. Proc. Natl. Acad. Sci. USA 1991, 88:11559-11563.
16. Skoch J., Hickey G.A., Kajdasz S.T., Hyman B.T., Bacskai B.J. Methods Mol. Biol. 2005, 299:349-363.
17. Pan T., Kondo S., Zhu W., Xie W., Jankovic J., Le W. Neurobiol. Dis. 2008, 32:16-25.
18. Alvarez-Fischer D., Guerreiro S., Hunot S., Saurini F., Marien M., Sokoloff P., Hirsch E.C., Hartmann A., Michel P.P. J. Neurochem. 2008, 107:701-711.
19. Vinchon-Petit S., Jarnet D., Michalak S., Lewis A., Benoit J.P., Menei P. Int. J. Pharm. 2010, 402:184-189.
20. Svoboda K., Denk W., Kleinfeld D., Tank D.W. Nature 1997, 385:161-165.
21. Xu H.T., Pan F., Yang G., Gan W.B. Nat. Neurosci. 2007, 10:549-551.
22. Yan P., Bero A.W., Cirrito J.R., Xiao Q., Hu X., Wang Y., Gonzales E., Holtzman D.M., Lee J.M. J. Neurosci. 2009, 29:10706-10714.